18th Nov 2009 16:37
Annex DTR3
Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons
All relevant boxes should be completed in block capital letters
|
Name of the Issuer: Hikma Pharmaceuticals PLC |
State whether the notification relates to (i) a transaction notified in accordance with DTR 3.1.2 R, (ii) a disclosure made in accordance with LR 9.8.6R(1) or (iii) a disclosure made in accordance with section 793 of the Companies Act (2006): DTR 3.1.2 R |
||
|
Name of person discharging managerial responsibilities/director: Samih Darwazah, Said Darwazah, Mazen Darwazah and Ali Al-Husry |
State whether notification relates to a person connected with a person discharging managerial responsibilities/ director named in 3 and identify the connected person: Yes: Darhold Limited |
||
|
Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non-beneficial interest: Beneficial interest Darhold Limited |
Description of shares (including class), debentures or derivatives or financial instruments relating to shares: Ordinary Shares |
||
|
Name of registered shareholders(s) and, if more than one, the number of shares held by each of them: Clearstream account for and on behalf of Europe Arab Bank plc |
State the nature of the transaction: A pledge over 11,500,000 Ordinary Shares in support of a loan |
||
|
Number of shares, debentures or financial instruments relating to shares acquired: None |
Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage): N/A |
||
|
Number of shares, debentures or financial instruments relating to shares disposed: None |
Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage): N/A |
||
|
Price per share or value of transaction: N/A |
Date and place of transaction: London, 16 November 2009 |
||
|
Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage): 57,183,028 - 29.9 per cent. |
Date issuer informed of transaction: 18 November 2009 |
|
If a person discharging managerial responsibilities has been granted options by the issuer complete the following boxes |
|||
|
Date of grant |
Period during which or date on which exercisable |
||
|
Total amount paid (if any) for grant of the option |
Description of shares or debentures involved (class and number) |
||
|
Exercise price (if fixed at time of grant) or indication that price is to be fixed at the time of exercise |
Total number of shares or debentures over which options held following notification |
||
|
Any additional information |
Name of contact and telephone number for queries |
||
|
Name of authorised official or issuer responsible for making notification: Henry Knowles |
|
Date of notification 18 November 2009 |
Notes:
This form is intended for use by an issuer to make a RIS notification required by DTR 3.1.4
(1) An issuer making a notification in respect of a transaction relating to the shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24.
(2) An issuer making a notification in respect of a derivative relating the shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14, 16, 23 and 24.
(3) An issuer making a notification in respect of options granted to a director/person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24.
(4) An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24.
Related Shares:
Hikma Pharmaceuticals